Recro Pharma
REPH
#9059
Rank
HK$0.95 B
Marketcap
HK$16.27
Share price
-0.48%
Change (1 day)
-28.38%
Change (1 year)

Revenue for Recro Pharma (REPH)

Revenue in 2021 (TTM): HK$0.58 Billion

According to Recro Pharma 's latest financial reports the company's current revenue is HK$0.58 Billion. In 2020 the company made a revenue of HK$0.51 Billion a decrease over the revenue in the year 2019 that were of HK$0.77 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Recro Pharma from 2016 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)HK$0.58 B13.28%
2020HK$0.51 B-32.98%
2019HK$0.77 B28.28%
2018HK$0.60 B7.67%
2017HK$0.55 B3.6%
2016HK$0.53 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
HK$717.34 B 122,178.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$0.78 B 33.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
HK$5.57 B 851.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
HK$5.06 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$55.55 M-90.53%๐Ÿ‡บ๐Ÿ‡ธ USA